- Home
- JYNT vs SCPH Comparison
JYNT vs SCPH Comparison
Compare JYNT & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- SCPH
- Stock Information
- Founded
- JYNT 2010
- SCPH 2013
- Country
- JYNT United States
- SCPH United States
- Employees
- JYNT N/A
- SCPH N/A
- Industry
- JYNT Multi-Sector Companies
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- JYNT Miscellaneous
- SCPH Health Care
- Exchange
- JYNT Nasdaq
- SCPH Nasdaq
- Market Cap
- JYNT 163.0M
- SCPH 163.3M
- IPO Year
- JYNT 2014
- SCPH 2017
- Fundamental
- Price
- JYNT $11.70
- SCPH $5.40
- Analyst Decision
- JYNT Strong Buy
- SCPH Strong Buy
- Analyst Count
- JYNT 2
- SCPH 2
- Target Price
- JYNT $18.00
- SCPH $19.00
- AVG Volume (30 Days)
- JYNT 46.8K
- SCPH 258.3K
- Earning Date
- JYNT 11-07-2024
- SCPH 11-06-2024
- Dividend Yield
- JYNT N/A
- SCPH N/A
- EPS Growth
- JYNT N/A
- SCPH N/A
- EPS
- JYNT N/A
- SCPH N/A
- Revenue
- JYNT $120,071,078.00
- SCPH $24,048,000.00
- Revenue This Year
- JYNT $0.70
- SCPH $195.62
- Revenue Next Year
- JYNT N/A
- SCPH $145.07
- P/E Ratio
- JYNT N/A
- SCPH N/A
- Revenue Growth
- JYNT 7.46
- SCPH 549.77
- 52 Week Low
- JYNT $7.31
- SCPH $3.24
- 52 Week High
- JYNT $17.82
- SCPH $7.55
- Technical
- Relative Strength Index (RSI)
- JYNT 51.57
- SCPH 60.05
- Support Level
- JYNT $10.80
- SCPH $4.97
- Resistance Level
- JYNT $12.02
- SCPH $5.40
- Average True Range (ATR)
- JYNT 0.40
- SCPH 0.23
- MACD
- JYNT 0.14
- SCPH 0.00
- Stochastic Oscillator
- JYNT 81.10
- SCPH 91.38
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.